1006 related articles for article (PubMed ID: 28612913)
1. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
2. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.
Gawor M; Śpiewak M; Kubik A; Wróbel A; Lutyńska A; Marczak M; Grzybowski J
Biomarkers; 2018 Nov; 23(7):676-682. PubMed ID: 29737871
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function.
Yakar Tülüce S; Tülüce K; Çil Z; Emren SV; Akyıldız Zİ; Ergene O
Anatol J Cardiol; 2016 May; 16(5):344-8. PubMed ID: 26488381
[TBL] [Abstract][Full Text] [Related]
4. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
[TBL] [Abstract][Full Text] [Related]
5. Troponin as ischemic biomarker is related with all three echocardiographic risk factors for sudden death in hypertrophic cardiomyopathy (ESC Guidelines 2014).
Hładij R; Rajtar-Salwa R; Dimitrow PP
Cardiovasc Ultrasound; 2017 Sep; 15(1):24. PubMed ID: 28903763
[TBL] [Abstract][Full Text] [Related]
6. Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
Hasler S; Manka R; Greutmann M; Gämperli O; Schmied C; Tanner FC; Biaggi P; Lüscher TF; Keller DI; Gruner C
Swiss Med Wkly; 2016; 146():w14285. PubMed ID: 26999566
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
9. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
Jenab Y; Pourjafari M; Darabi F; Boroumand MA; Zoroufian A; Jalali A
J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
[TBL] [Abstract][Full Text] [Related]
11. Soluble ST2, Galectin-3 and clinical prognosis of patients with hypertrophic cardiomyopathy undergoing ventricular septal myectomy: a correlation analysis.
Song B; Yao B; Dang H; Dong R
Cardiovasc Diagn Ther; 2020 Apr; 10(2):145-152. PubMed ID: 32420094
[TBL] [Abstract][Full Text] [Related]
12. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
[TBL] [Abstract][Full Text] [Related]
14. Elevated Level of Troponin but Not N-Terminal Probrain Natriuretic Peptide Is Associated with Increased Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy Calculated According to the ESC Guidelines 2014.
Rajtar-Salwa R; Hładij R; Dimitrow PP
Dis Markers; 2017; 2017():9417908. PubMed ID: 29358842
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the association between serum uric acid level andthe predicted risk score of sudden cardiac death in five years in patients with hypertrophic cardiomyopathy.
Özyılmaz S; Satılmışoğlu MH; Gül M; Uyarel H; Serdar OA
Turk Kardiyol Dern Ars; 2018 Mar; 46(2):111-120. PubMed ID: 29512627
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
[TBL] [Abstract][Full Text] [Related]
17. Profiles of cardiovascular biomarkers according to severity stages of Chagas cardiomyopathy.
Echeverría LE; Rojas LZ; Calvo LS; Roa ZM; Rueda-Ochoa OL; Morillo CA; Muka T; Franco OH
Int J Cardiol; 2017 Jan; 227():577-582. PubMed ID: 27839809
[TBL] [Abstract][Full Text] [Related]
18. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction.
Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Balsam P; Opolski G; Filipiak KJ
Dis Markers; 2019; 2019():9529053. PubMed ID: 31687050
[TBL] [Abstract][Full Text] [Related]
19. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
